Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Ocumension Therapeutics ( (HK:1477) ) just unveiled an announcement.
Ocumension Therapeutics announced that all resolutions proposed at their Annual General Meeting on June 19, 2025, were passed as ordinary resolutions. Key resolutions included the re-election of directors, the re-appointment of auditors, and the authorization for the board to manage shares, reflecting strong shareholder support and potentially enhancing the company’s governance and operational capabilities.
The most recent analyst rating on (HK:1477) stock is a Buy with a HK$7.29 price target. To see the full list of analyst forecasts on Ocumension Therapeutics stock, see the HK:1477 Stock Forecast page.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, primarily involved in the healthcare sector with a focus on therapeutic solutions.
Average Trading Volume: 6,700,567
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.29B
For detailed information about 1477 stock, go to TipRanks’ Stock Analysis page.